186 related articles for article (PubMed ID: 33077619)
1. The Impact of Circulating Antibody on Group B
Vaz MJ; Purrier SA; Bonakdar M; Chamby AB; Ratner AJ; Randis TM
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077619
[TBL] [Abstract][Full Text] [Related]
2. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
[TBL] [Abstract][Full Text] [Related]
3. A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
Buurman ET; Timofeyeva Y; Gu J; Kim JH; Kodali S; Liu Y; Mininni T; Moghazeh S; Pavliakova D; Singer C; Singh S; Handke LD; Lotvin J; Prasad AK; Scully IL; Donald RGK; Jansen KU; Anderson AS
J Infect Dis; 2019 Jun; 220(1):105-115. PubMed ID: 30778554
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
[TBL] [Abstract][Full Text] [Related]
5. Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.
Baker JA; Lewis EL; Byland LM; Bonakdar M; Randis TM; Ratner AJ
Vaccine; 2017 Mar; 35(9):1273-1280. PubMed ID: 28162823
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent presence of antibodies in rat dams, capable of conferring protection against group B Streptococcus infection in neonates.
Moore JC; Muckett PJ; Hughes MJ
FEMS Microbiol Lett; 2001 Aug; 202(1):125-7. PubMed ID: 11506919
[TBL] [Abstract][Full Text] [Related]
7. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
[TBL] [Abstract][Full Text] [Related]
8. Capsule production promotes Group B
Vaz MJ; Dongas S; Ratner AJ
Microbiol Spectr; 2023 Sep; 11(5):e0234923. PubMed ID: 37732775
[TBL] [Abstract][Full Text] [Related]
9. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
10. Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.
Bernardini R; Aufieri R; Detcheva A; Recchia S; Cicconi R; Amicosante M; Montesano C; Rossi P; Tchidjou HK; Petrunov B; Orefici G; Mattei M
J Matern Fetal Neonatal Med; 2017 Dec; 30(23):2844-2850. PubMed ID: 27973991
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
[TBL] [Abstract][Full Text] [Related]
12. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
[TBL] [Abstract][Full Text] [Related]
13. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
[TBL] [Abstract][Full Text] [Related]
14. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
15. Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection.
Chiarot E; Naimo E; Corrado A; Giannetti P; Ros IMY; Bensi G
Sci Rep; 2021 Nov; 11(1):21384. PubMed ID: 34725414
[TBL] [Abstract][Full Text] [Related]
16. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
17. A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.
Alves J; Madureira P; Baltazar MT; Barros L; Oliveira L; Dinis-Oliveira RJ; Andrade EB; Ribeiro A; Vieira LM; Trieu-Cuot P; Duarte JA; Carvalho F; Ferreira P
PLoS One; 2015; 10(12):e0144196. PubMed ID: 26673420
[TBL] [Abstract][Full Text] [Related]
18. FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions.
Buscetta M; Papasergi S; Firon A; Pietrocola G; Biondo C; Mancuso G; Midiri A; Romeo L; Teti G; Speziale P; Trieu-Cuot P; Beninati C
J Biol Chem; 2014 Jul; 289(30):21003-21015. PubMed ID: 24904056
[TBL] [Abstract][Full Text] [Related]
19. Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice.
Lin SM; Jang AY; Zhi Y; Gao S; Lim S; Lim JH; Song JY; Sullam PM; Rhee JH; Seo HS
J Infect Dis; 2017 Dec; 217(1):93-102. PubMed ID: 29106586
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization.
Dos Santos NFB; da Silva LR; Costa FJMD; de Mattos DM; de Carvalho E; Ferreira LCS; Ferreira RCC
Vaccine; 2020 Jul; 38(33):5286-5296. PubMed ID: 32571719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
